To fix a patient’s irregular heartbeat, doctors first tested its digital ‘twin’
AI Summary
Researchers at Johns Hopkins University have developed digital "twins" of patients' hearts to improve treatment for ventricular tachycardia, a dangerous irregular heartbeat. The FDA allowed the technology to guide treatment for 10 patients in a small clinical trial. These custom models, created using advanced MRI scans and other patient data, simulate treatment approaches on the virtual heart to predict how the real organ will react. Doctors can then use this information to better target ablation, the main treatment for the condition, where catheters are used to burn misfiring tissue. The study, published in the New England Journal of Medicine, suggests digital twins could improve care for this condition, which contributes to approximately 300,000 U.S. deaths a year. Larger studies are needed to confirm these findings.
Article Analysis
Key Claims (5)
AI-Extracted"This is what we envisioned."
The FDA allowed the digital twin technology to guide treatment for just 10 patients.
Ventricular tachycardia is a major cause of sudden cardiac arrest, blamed for about 300,000 U.S. deaths a year.
Scientists created virtual replicas of patients’ diseased hearts to improve treatment.
The study suggests it might improve care for ventricular tachycardia.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis.
Topic Connections
Explore how the topics in this article connect to other news stories
Find Similar Articles
AI-PoweredDiscover articles with similar content using semantic similarity analysis.